https://www.prnewswire.com/news-releases/qrxpharma-signs-license-and-option-agreement-with-actavis-143301976.html
/PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of its License and Option Agreement (LOA) with Actavis, Inc. which...
option agreementsignslicenseactavis
https://www.biospace.com/press-releases/araris-biotech-ag-announces-research-collaboration-and-option-to-license-agreement-with-chugai-pharmaceutical-co-to-develop-next-generation-adcs-using-araris-aralinq-technology
biotechagannouncesresearchcollaboration
https://www.streetwisereports.com/article/2024/10/04/uranium-co-enters-agreement-to-option-athabasca-basin-projects.html?m_t=2024_10_07_09_42_53
Skyharbour Resources Ltd. (SYH:TSX.V; SYHBF:OTCQX; SC1P:FSE) announces an option agreement in which a private arm's-length company can acquire up to a 100%...
athabasca basinuraniumcoentersagreement
https://www.businesswire.com/news/home/20250915030511/en/VarmX-Partners-With-CSL-in-a-Strategic-Collaboration-and-Option-Agreement-to-Develop-Novel-Investigational-Coagulation-Treatment
VarmX partners with CSL in a strategic collaboration and option agreement to develop novel investigational blood coagulation treatment VMX-C001.
partnerscslstrategiccollaborationoption